
Nuevocor
Operator of a biotechnology firm intended to develop gene therapies for the treatment of cardiovascular disease. The company focuses on genetic cardiomyopathies characterized by aberrant mechanobiolog...
Valuation
$0
Share Price
N/A
Total Raised
$80.6M
Last Round
N/A